Viewing nowHLB Simvastatin Tablets 20 mg
Simvastatin 20mg
Tablet · Prescription medication
HLB Pharma Co., Ltd.

MFDS item code 200401924 · Notified 2004.06.18 · Insurance code 647300740
Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease
This medication helps reduce the risk of cardiovascular diseases, particularly in patients with high risks for coronary artery disease, stroke, and peripheral vascular disease, lowering the risk of death from coronary artery disease, myocardial infarction, and stroke. It also reduces the risk of complications after vascular interventions. This drug is used in the treatment of hyperlipidemia, effectively lowering total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels, while increasing HDL cholesterol. It helps improve lipid levels when combined with diet in pediatric patients with heterozygous familial hypercholesterolemia. Thus, this medication is widely used for managing cardiovascular diseases and hyperlipidemia.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of risk of cardiovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate based on the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine, particularly during the first year of treatment, should be given only to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity. (1) Administration to patients with homozygous familial hypercholesterolemia Results of controlled clinical trials show that patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not possible. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Coadministration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil and fenofibrate), its dose must not exceed 10 mg per day. (6) Administration to patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, start with an initial dose of 5 mg per day and monitor carefully.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or more between dose adjustments.
This medication is primarily used to lower cholesterol. However, caution is needed as muscle problems may occur while taking this drug. Especially at higher doses, the risk of serious muscle damage known as myopathy or rhabdomyolysis may increase. Patients taking this medication at high doses should inform their doctor immediately if they experience muscle pain or weakness. Additionally, because this drug is metabolized in the liver, it should not be used in patients with poor liver function or liver disease. Women who are pregnant, potentially pregnant, or breastfeeding should not take this medication. This drug should not be taken with other medications that interfere with liver metabolism, such as certain antibiotics, antifungals, and immunosuppressants, as this increases the risk of side effects. Furthermore, individuals who excessively consume alcohol, have poor kidney function, hypothyroidism, the elderly, and females should be especially cautious when taking this medication. Rarely, various side effects such as liver dysfunction, blood abnormalities, skin rashes, digestive disorders, and neurological issues may occur, so any unusual symptoms should prompt immediate consultation with a healthcare provider. It is advisable to regularly check liver function and muscle status through blood tests during treatment. Additionally, it is safe to avoid certain foods like grapefruit juice during the course of this medication. Finally, this medication is not recommended for children, especially females under 10 years old or before menarche.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air ingress, and it is best kept at room temperature between 1 and 30 degrees Celsius. This will help maintain the drug's effectiveness.
Brownish-yellow oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
HLB Pharma Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.